Tiger Global’s Tech Stock Picks Include Amazon.com, Inc. (AMZN)

The 13F shows that Tiger Global was also selling Amazon.com, Inc. (NASDAQ:AMZN) during the quarter, yet as with Priceline the fund maintained a strong position in the e-commerce company. Amazon.com, Inc. (NASDAQ:AMZN)’s profits remain low, though investors argue that the company is currently making investments in new business capabilities which will pay off in the form of higher profits later on. We’re skeptical of that reasoning, and with a forward P/E of 81 we would avoid the stock. Fisher Asset Management, managed by billionaire Ken Fisher, has been another major shareholder in Amazon (check out more stocks Fisher owns).

Baidu.com, Inc. (ADR) (NASDAQ:BIDU) was another of the fund’s top tech picks with the filing disclosing ownership of 2.6 million shares. The Chinese search engine and Internet portal saw a shrinkage in its net margins recently, per the company’s quarterly reports: while revenue grew 40% in its most recent quarter compared to the same period in the previous year, earnings grew by only 9%. That’s still a decent growth rate from a business point of view, but even with Baidu.com, Inc. (ADR) (NASDAQ:BIDU)’s stock price falling 19% in the last year the stock is priced at 20 times its trailing earnings and so might be too expensive.

Tiger Global nearly doubled the size of its position in Motorola Solutions Inc (NYSE:MSI), the $16 billion market cap communications equipment company. At that valuation, the stock trades at 14 times forward earnings estimates. From that point it would need further growth in order to justify the current price, so it might be best to wait for a couple more quarters of financial data from the company. Billionaire George Soros had been selling some of its Motorola Solutions Inc (NYSE:MSI) stock at the end of last year, but still closed 2012 with 2.6 million shares in his portfolio (research more stocks Soros liked).

Disclosure: I own no shares of any stocks mentioned in this article.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!